Skip to main content

Table 4 Multivariate analysis of volumetric parameter cut-off values compared to survival outcomes

From: The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy

 

LRPFS

PFS

OS

HR (95% CI)

p

HR (95% CI)

p

HR (95% CI)

p

Sex (Male vs. Female)

 

NS

 

NS

 

NS

Histology (SqCC vs. Others)

 

NS

1.455 (0.983–2.155)

0.061

 

NS

T stage (T1-T2 vs. T3-T4)

 

NS

 

NS

 

NS

N stage (N0-N2 vs. N3)

 

NS

 

NS

 

NS

Stage (IIIA vs. IIIB)

 

NS

 

NS

 

NS

GTVpre (≤ 50 cm3 vs. > 50 cm3)

2.926 (1.495–5.726)

0.002

2.001 (1.159–3.454)

0.013

2.763 (1.552–4.919)

0.001

GTVpost (≤ 20 cm3 vs. > 20 cm3)

 

NS

1.467 (0.947–2.273)

0.086

 

NS

VRR (≤ 50% vs. > 50%)

 

NS

 

NS

1.895 (0.937–3.832)

0.075

  1. Abbreviations: CI Confidence interval, GTV pre Initial gross tumor volume CT, GTV post follow-up gross tumor volume, HR Hazard ratio, LRPFS Locoregional progression-free survival rate, NS No significance, OS Overall survival rate, PFS Progression-free survival rate, SqCC Squamous cell carcinoma, VRR Reduction ratio of gross tumor volume.